alexa
Reach Us +44-3308187254

GET THE APP

Dersleri yüzünden oldukça stresli bir ruh haline sikiş hikayeleri bürünüp özel matematik dersinden önce rahatlayabilmek için amatör pornolar kendisini yatak odasına kapatan genç adam telefonundan porno resimleri açtığı porno filmini keyifle seyir ederek yatağını mobil porno okşar ruh dinlendirici olduğunu iddia ettikleri özel sex resim bir masaj salonunda çalışan genç masör hem sağlık hem de huzur sikiş için gelip masaj yaptıracak olan kadını gördüğünde porn nutku tutulur tüm gün boyu seksi lezbiyenleri sikiş dikizleyerek onları en savunmasız anlarında fotoğraflayan azılı erkek lavaboya geçerek fotoğraflara bakıp koca yarağını keyifle okşamaya başlar
High Throughput Optimization And Mass Spectrometric Analysis Of Covalently Labeled Proteins And Antibody Drug Conjugates | 79347
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

High throughput optimization and mass spectrometric analysis of covalently labeled proteins and antibody drug conjugates

Joint Event on 4th European Biopharma Congress & 6th International Conference and Exhibition on Pharmacology and Ethnopharmacology

Chawita Netirojjanakul, Iain D G Campuzano, Aiko Umeda, Nelson M Carramanzana, Tisha San Miguel and Jason Long

Amgen, USA

ScientificTracks Abstracts: Clin Pharmacol Biopharm

DOI: 10.4172/2167-065X-C1-025

Abstract
The use of automated high throughput screening in large molecule discovery research still lags behind that of small molecule discovery. Recently we developed a high-throughput large molecule discovery platform to automate hundreds of bioconjugation reaction setup in one setting. In addition, given LC-MS is a widespread analytical bottleneck, we also established a high-throughput mass spectrometry (HT-MS) platform to accurately detect and rapidly quantitate protein conjugates. We showed that our HT-MS platform can be used to quantitate the extent of covalent inhibitor adducts to a cysteine-containing protein construct (~19 kDa) and of biotinylated adducts to mAbs and Fc domains (~150 and ~50 kDa, respectively). Sample acquisition time was ~20 seconds per sample, 10-50x shorter time than traditional LC-MS methods. Site-specific bioconjugation of human Fc domains with cysteine engineered at different positions were conducted under a matrix of reaction conditions varying equivalents of reductants, oxidants, and alkylating agents using the high-throughput large molecule discovery platform. Using HT-MS, 4 x 384 well plates were analyzed in ~8 hours, as opposed to ~11 days using traditional LC-MS. This approach facilitated rapid determination of DAR values for the reduced and intact huFc domains and selection of optimized conditions for different cysteine-engineered Fc constructs which will be used in preparation of Fc-peptide conjugates as therapeutic leads.
Biography

Chawita Netirojjanakul received her BSc in chemistry from MIT, conducting research in the laboratory of Prof. John Essigmann (MIT) and Prof. Steve Ley (Cambridge). After graduation, she pursued her interest in science policy and commercialization studying MPhil in Technology Policy at University of Cambridge, UK, as a Gates Scholar. She received HHMI International Student Research Fellowship to conduct PhD research under the supervision of Prof. Matthew Francis in the Chemistry Department at UC Berkeley with a focus on "development and applications of well-defined antibody and antibody fragment bioconjugates."  She is a Scientist in Therapeutic Discovery Department at Amgen.
 

Top